| Identification | Back Directory | [Name]
L-Proline, L-leucyl-L-prolyl-L-prolyl-L-leucyl-L-prolyl-L-tyrosyl- | [CAS]
877120-59-7 | [Synonyms]
L-Proline, L-leucyl-L-prolyl-L-prolyl-L-leucyl-L-prolyl-L-tyrosyl- | [Molecular Formula]
C41H61N7O9 | [MOL File]
877120-59-7.mol | [Molecular Weight]
795.96 |
| Chemical Properties | Back Directory | [Boiling point ]
1113.1±65.0 °C(Predicted) | [density ]
1.292±0.06 g/cm3(Predicted) | [pka]
3.40±0.20(Predicted) | [Sequence]
Leu-Pro-Pro-Leu-Pro-Tyr-Pro |
| Hazard Information | Back Directory | [Uses]
IPL344 protects cells of various types from pro-apoptotic pressures and activates the Akt signaling system. IPL344 can be used for research of amyotrophic lateral sclerosis (ALS)[1][2]. | [References]
[1] Eran Ovadia, et al. Peptide compounds and methods of treating diseases using same. Patent. WO 2021/144798 Al
[2] Meglio M. Akt Activator IPL344 Demonstrates Safety, Signs of Efficacy in Phase 1/2 Study of ALS[J]. Neurology Times, 2022: NA-NA. |
|
|